Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

BTX

Brooklyn ImmunoTherapeut... (BTX)

Brooklyn ImmunoTherapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BTX
DateTimeSourceHeadlineSymbolCompany
12/05/202306:35Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BTXBrooklyn ImmunoTherapeutics Inc
10/05/202320:02Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:BTXBrooklyn ImmunoTherapeutics Inc
05/05/202321:02Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:BTXBrooklyn ImmunoTherapeutics Inc
05/05/202321:02Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:BTXBrooklyn ImmunoTherapeutics Inc
05/05/202321:01Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:BTXBrooklyn ImmunoTherapeutics Inc
05/05/202320:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BTXBrooklyn ImmunoTherapeutics Inc
25/04/202323:02Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:BTXBrooklyn ImmunoTherapeutics Inc
21/04/202306:31Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:BTXBrooklyn ImmunoTherapeutics Inc
11/04/202321:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BTXBrooklyn ImmunoTherapeutics Inc
05/04/202307:15Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BTXBrooklyn ImmunoTherapeutics Inc
05/04/202307:05Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:BTXBrooklyn ImmunoTherapeutics Inc
21/03/202323:39Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:BTXBrooklyn ImmunoTherapeutics Inc
07/03/202308:06Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:BTXBrooklyn ImmunoTherapeutics Inc
27/01/202308:32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BTXBrooklyn ImmunoTherapeutics Inc
11/01/202308:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BTXBrooklyn ImmunoTherapeutics Inc
05/01/202300:36Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BTXBrooklyn ImmunoTherapeutics Inc
21/12/202208:31Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:BTXBrooklyn ImmunoTherapeutics Inc
17/12/202209:01Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:BTXBrooklyn ImmunoTherapeutics Inc
15/12/202208:31Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:BTXBrooklyn ImmunoTherapeutics Inc
07/12/202210:52Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BTXBrooklyn ImmunoTherapeutics Inc
07/12/202208:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BTXBrooklyn ImmunoTherapeutics Inc
06/12/202209:21Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BTXBrooklyn ImmunoTherapeutics Inc
05/12/202222:04Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BTXBrooklyn ImmunoTherapeutics Inc
03/12/202209:01Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:BTXBrooklyn ImmunoTherapeutics Inc
23/11/202208:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BTXBrooklyn ImmunoTherapeutics Inc
15/11/202208:57Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BTXBrooklyn ImmunoTherapeutics Inc
25/10/202207:32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BTXBrooklyn ImmunoTherapeutics Inc
15/10/202207:34Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BTXBrooklyn ImmunoTherapeutics Inc
11/10/202223:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BTXBrooklyn ImmunoTherapeutics Inc
11/10/202223:30GlobeNewswire Inc.Brooklyn ImmunoTherapeutics Announces Name Change to Eterna Therapeutics and Provides Corporate UpdatesNASDAQ:BTXBrooklyn ImmunoTherapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:BTX